"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Descriptor ID |
D007166
|
MeSH Number(s) |
D27.505.696.477.656
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 3 | 3 | 6 |
1996 | 8 | 3 | 11 |
1997 | 5 | 7 | 12 |
1998 | 11 | 11 | 22 |
1999 | 6 | 6 | 12 |
2000 | 14 | 10 | 24 |
2001 | 9 | 8 | 17 |
2002 | 11 | 9 | 20 |
2003 | 13 | 20 | 33 |
2004 | 18 | 19 | 37 |
2005 | 16 | 10 | 26 |
2006 | 13 | 23 | 36 |
2007 | 15 | 15 | 30 |
2008 | 13 | 30 | 43 |
2009 | 10 | 18 | 28 |
2010 | 18 | 20 | 38 |
2011 | 14 | 11 | 25 |
2012 | 11 | 15 | 26 |
2013 | 13 | 11 | 24 |
2014 | 18 | 19 | 37 |
2015 | 16 | 21 | 37 |
2016 | 14 | 9 | 23 |
2017 | 23 | 18 | 41 |
2018 | 14 | 13 | 27 |
2019 | 7 | 15 | 22 |
2020 | 12 | 17 | 29 |
2021 | 13 | 11 | 24 |
2022 | 0 | 19 | 19 |
2023 | 1 | 13 | 14 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy. Drug Saf. 2024 Apr; 47(4):321-332.
-
Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy. Pediatr Blood Cancer. 2024 Apr; 71(4):e30873.
-
Selective reprogramming of regulatory T cells in solid tumors can strongly enhance or inhibit tumor growth. Front Immunol. 2023; 14:1274199.
-
Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case series and review of the literature. BMC Anesthesiol. 2023 09 12; 23(1):310.
-
External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant. Pharmacotherapy. 2023 07; 43(7):650-658.
-
Immune Checkpoint Inhibitor-Associated Nephrotoxicity. Nephron. 2024; 148(1):11-15.
-
Pathogenic cellular and molecular mediators in lupus nephritis. Nat Rev Nephrol. 2023 08; 19(8):491-508.
-
International cohort of 382 children with lupus nephritis - presentation, treatment and outcome at 24?months. Pediatr Nephrol. 2023 11; 38(11):3699-3709.
-
Immunosuppressive Therapy in Solid Organ Transplantation: Primer for Radiologists and Potential Complications. Radiol Clin North Am. 2023 Sep; 61(5):913-932.
-
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2023 06; 43(6):473-484.